Advair Alvesco combination therapy:AVEC study

Advair Alvesco combination therapy:AVEC study - Advair Alvesco combination therapy:AVEC study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012189

Enrollment

Registered

2013-10-31

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchial asthma

Interventions

one(ICS, inhaled corticosteroid) three month, one year two(ICS, inhaled corticosteroid) three month, one year

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: bronchial asthma patient

Exclusion criteria

Exclusion criteria: Pregnant

Design outcomes

Primary

Measure	Time frame
Improvement degree of the asthmatic control marker	—

Countries

Japan

Contacts

Public ContactTakehito Kobayashi

Saitama Medical University Hospital Department of General Internal Medicine

kobatake@saitama-med.ac.jp049-276-1667

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026